Using mHealth to Aid Opioid Addicts
NCT01955902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2013-11-11
Summary
The purpose of the proposed study is perform focus groups to identify and prioritize features of the SubAID application (APP). The SubAID APP is smartphone APP being created to support patients self-managing buprenorphine/naloxone (bup/nal) medication. Many people have difficulty in managing bup/nal in the prescribed manner. Not taking medicines in their prescribed manner can cause negative health outcomes.
Focus group participants will be asked to elaborate on medication-taking patterns that work best for them, pitfalls associated with poor adherence and offer opinions upon what features/functions the SubAID APP should perform to be most helpful to them. The focus group is designed to remain open-ended and allow free discussion regarding each particular topic that the moderator will bring up.
Conditions
- Opiate Dependency Relapse
Sponsors & Collaborators
-
Care Team Solutions
lead INDUSTRY
Principal Investigators
-
Michael Bailey, PhD · Care Team Solutions
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- United States
Study Locations
More Related Trials
-
mHealth for Patient Self-Management of Opioid Use Disorder
NCT03633929 ·Status: COMPLETED
-
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
NCT06454903 ·Status: RECRUITING ·Phase: NA
-
Prevention Interventions for Opioid Misuse
NCT04550715 ·Status: COMPLETED ·Phase: NA
-
Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth
NCT02712034 ·Status: COMPLETED ·Phase: NA
-
Effects of Remote Motivational Enhancement & MySafeRx on Post-Detox Engagement in B/N Treatment -RCT
NCT04822168 ·Status: WITHDRAWN ·Phase: NA
-
Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention
NCT02990377 ·Status: COMPLETED ·Phase: NA
-
Mobile Health (mHealth) App for Safe Opioid Use
NCT04462250 ·Status: WITHDRAWN ·Phase: NA
-
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
NCT00367302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CBT4CBT for Office Based Buprenorphine
NCT03580902 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Suboxone Dispenser for OUD
NCT05790551 ·Status: WITHDRAWN ·Phase: NA
-
Mobile Intervention for Young Opioid Users
NCT03610672 ·Status: UNKNOWN ·Phase: NA
-
Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids
NCT05503186 ·Status: COMPLETED ·Phase: NA
-
Smartphones for Opiate Addiction Recovery
NCT05033028 ·Status: RECRUITING ·Phase: PHASE3
-
Remote Observed Dosing of Suboxone to Improve Clinical Practice
NCT03769025 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Linking Hospitalized Injection Drug Users to Buprenorphine
NCT00987961 ·Status: COMPLETED ·Phase: PHASE3
-
Remote Observed Dosing to Increase Suboxone Compliance
NCT01779973 ·Status: COMPLETED ·Phase: NA
-
MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
NCT02942199 ·Status: COMPLETED ·Phase: NA
-
OUD Smartphone Services
NCT06134882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment
NCT05189223 ·Status: RECRUITING ·Phase: NA
-
Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
NCT01637922 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
NCT00555425 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Office Based Treatment of Opioid Use Disorder With Technology
NCT03586466 ·Status: UNKNOWN ·Phase: NA
-
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
NCT00000243 ·Status: TERMINATED ·Phase: NA
-
Prescribe to Save Lives
NCT03175640 ·Status: COMPLETED ·Phase: NA
-
BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3
NCT02902835 ·Status: TERMINATED ·Phase: NA